Stock 6L7A BELLEROPHON THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Bellerophon Therapeutics, Inc. Börse Stuttgart

Equities

6L7A

US0787713009

Delayed Börse Stuttgart
Other stock markets
 11:31:13 13/10/2023 am IST 		5-day change 1st Jan Change
0.421 EUR +20.98% Intraday chart for Bellerophon Therapeutics, Inc. +26.05% -45.08%
02/05 North American Morning Briefing : Stock Futures -2- DJ
25/04 North American Morning Briefing : More Tech -2- DJ

Evolution of the average Target Price on Bellerophon Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

af5caa1b0b993b210c9dd8ae9.2DCwsKlmA4B3rSsphILVTcwcBnHyoJX3UxjHqmBBe-Y.j0jJ-N0OVMEy2h4Es_DiO44tSUSD_-LFHHWX2yIFHtKoatPhwzwu5DLqeg~f2bb41397868ed141d85adcb8d77d355

Analyst Recommendations on Bellerophon Therapeutics, Inc.

North American Morning Briefing : More Tech -2- DJ
HC Wainwright Adjusts Bellerophon Therapeutics Price Target to $2 From $30, Maintains Buy Rating MT
Brookline Capital Downgrades Bellerophon Therapeutics to Hold From Buy MT
Laidlaw Downgrades Bellerophon Therapeutics to Hold From Buy MT
Laidlaw Initiates Bellerophon Therapeutics at Buy With $35 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.0564
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Analysts covering Bellerophon Therapeutics, Inc.

HC Wainwright
Laidlaw & Co.
Brookline Capital Markets

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BLPH Stock
  4. 6L7A Stock
  5. Consensus Bellerophon Therapeutics, Inc.